These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24353157)

  • 21. How can innovative forms of clinical research contribute to deliver affordable cancer care in an evolving health care environment?
    Burock S; Meunier F; Lacombe D
    Eur J Cancer; 2013 Sep; 49(13):2777-83. PubMed ID: 23777742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare.
    Wellenreuther R; Keppler D; Mumberg D; Ziegelbauer K; Lessl M
    Drug Discov Today; 2012 Nov; 17(21-22):1242-8. PubMed ID: 22521665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The PCAST report: impact and implications for the pharmaceutical industry.
    Morris SA; Rosenblatt M; Orloff JJ; Lewis-Hall F; Waldstreicher J
    Clin Pharmacol Ther; 2013 Sep; 94(3):300-2. PubMed ID: 23963216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspective: Graduation time.
    Russell DG; Nathan CF
    Nature; 2013 Oct; 502(7470):S7. PubMed ID: 24108080
    [No Abstract]   [Full Text] [Related]  

  • 26. Public-private partnerships in translational medicine: concepts and practical examples.
    Luijten PR; van Dongen GA; Moonen CT; Storm G; Crommelin DJ
    J Control Release; 2012 Jul; 161(2):416-21. PubMed ID: 22465390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Innovative Medicines Initiative moves translational immunology forward.
    Goldman M; Wittelsberger A; De Magistris MT
    Eur J Immunol; 2013 Feb; 43(2):298-302. PubMed ID: 23534061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The innovative medicines initiative: a European response to the innovation challenge.
    Goldman M
    Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harnessing academia, government, and industry.
    Tumminia SJ
    Invest Ophthalmol Vis Sci; 2012 May; 53(5):2515-21. PubMed ID: 22562854
    [No Abstract]   [Full Text] [Related]  

  • 30. Next generation partnerships in translational science and medicine: Partnerships between academics, big pharma, biotech firms, philanthropists and patients look set to change the way science advances.
    Ljunggren HG; Chien KR
    EMBO Rep; 2015 Oct; 16(10):1246-9. PubMed ID: 26358954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An NIH National Center for Advancing Translational Sciences: is a focus on drug discovery the best option?
    Littman BH
    Nat Rev Drug Discov; 2011 Jun; 10(6):471. PubMed ID: 21597471
    [No Abstract]   [Full Text] [Related]  

  • 32. Into the valley of death: research to innovation.
    Hudson J; Khazragui HF
    Drug Discov Today; 2013 Jul; 18(13-14):610-3. PubMed ID: 23402848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. To the G20: incentivising antibacterial research and development.
    Årdal C; Baraldi E; Ciabuschi F; Outterson K; Rex JH; Piddock LJV; Findlay D;
    Lancet Infect Dis; 2017 Aug; 17(8):799-801. PubMed ID: 28689703
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug patent plan gets mixed reviews.
    Butler D
    Nature; 2009 Feb; 457(7233):1064. PubMed ID: 19256077
    [No Abstract]   [Full Text] [Related]  

  • 35. Medications development for substance-use disorders: contextual influences (dis)incentivizing pharmaceutical-industry positioning.
    Janero DR
    Expert Opin Drug Discov; 2014 Nov; 9(11):1265-79. PubMed ID: 25162124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Open innovation networks between academia and industry: an imperative for breakthrough therapies.
    Melese T; Lin SM; Chang JL; Cohen NH
    Nat Med; 2009 May; 15(5):502-7. PubMed ID: 19424212
    [No Abstract]   [Full Text] [Related]  

  • 37. Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation.
    Patel AC; Coyle AJ
    Clin Pharmacol Ther; 2013 Sep; 94(3):314-6. PubMed ID: 23645247
    [No Abstract]   [Full Text] [Related]  

  • 38. Boosting translational research on Alzheimer's disease in Europe: The Innovative Medicine Initiative AD research platform.
    Vaudano E; Vannieuwenhuyse B; Van Der Geyten S; van der Lei J; Visser PJ; Streffer J; Ritchie C; McHale D; Lovestone S; Hofmann-Apitius M; Truyen L; Goldman M
    Alzheimers Dement; 2015 Sep; 11(9):1121-2. PubMed ID: 25754460
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of product development partnerships in advancing the development of drugs for unmet needs.
    Breitstein J; Spigelman M
    Clin Pharmacol Ther; 2013 Jun; 93(6):468-70. PubMed ID: 23689211
    [No Abstract]   [Full Text] [Related]  

  • 40. The future is much closer collaboration between the pharmaceutical industry and academic medical centers.
    Vallance P; Williams P; Dollery C
    Clin Pharmacol Ther; 2010 May; 87(5):525-7. PubMed ID: 20407455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.